References
- Duvoix A, Blasius R, Diederich M, et al. Chemopreventive and therapeutic effects of curcumin. Cancer Lett. 2005;223:181–190.
- An FDA Investigation into Two Serious Adverse Events Associated with ImprimisRx’s Compounded Curcumin Emulsion Product for Injection. FDA, 8 August 2017. Available from: https://www.fda.gov/drugs/guidancecomplianceregulatoryinformation/pharmacycompounding/ucm570192.htm
- Fruijtier-Pölloth C. Safety assessment on polyethylene glycols (PEGs) and their derivatives as used in cosmetic products. Toxicology. 2005;214:1–38.